TMEM106B Synthetic Peptide, PEP-1396, from Invitrogen.
TMEM106B Synthetic Peptide, PEP-1396, from Invitrogen.
Transmembrane protein 106B (TMEM106B) is a single-pass transmembrane protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual role of TMEM106B, and that of the closely related protein TMEM106A are still undetermined.
Conservation
Storage: -20°C.
Formulation
Concentration: 200 μg/mL.
Regulatory status
Research only (RUO).
Packaging
Packaging: 50 μg.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15215309 |
| Specifications |
| Gene ID (Enter) | 54664 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9NUM4 |
| Common name | Human TMEM106B |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | TMEM106B |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
Origin and customs
| Manufacturer ref. | PEP-1396 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3824 99 92 00 |
|---|
A question or a specific configuration?
Contact us for a quote.